tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Recce Pharmaceuticals Opens Entitlement Offer to Raise $10.8 Million

Story Highlights
Recce Pharmaceuticals Opens Entitlement Offer to Raise $10.8 Million

Elevate Your Investing Strategy:

Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has provided an update.

Recce Pharmaceuticals Ltd. has announced the opening of a pro-rata non-renounceable entitlement offer, allowing eligible shareholders to purchase one new share for every six shares held at an issue price of $0.28 per share. This offer aims to raise approximately $10.8 million before costs, with the funds potentially enhancing the company’s operational capabilities and market position.

More about Recce Pharmaceuticals Ltd.

Recce Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development of synthetic anti-infectives. The company is known for its innovative approach to treating serious infections, positioning itself as a leader in the market for new-generation antibiotics.

YTD Price Performance: -39.58%

Average Trading Volume: 206,124

Technical Sentiment Signal: Buy

Current Market Cap: A$78.45M

For detailed information about RCE stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1